Good year briefly call, of briefly and Thank commercial revenue will highlights everyone. results for was our for On and with Obalon year will full I business grew Bill. the at am achieved the morning We with experience, a joining Thank commercialization. afterwards year transformational pleased QX. finished the have over a this discuss year today. XXXX first success and very QX of us I Obalon answer you, ended strong in you we and U.S. our questions. we full
East. of franchise quarter the increase was million in $X.X be expected is unaudited number over the revenues XXXX reorders we the XXXX. in for exceeded revenue fourth to continued and QX the highest we has quarter to for believe XX% sales, sales QX our month sustainable the preliminary growing our of the number largest first for approximately starts, order several X million, XX% registry, ever $X.X revenue and an encouraging XXX% fulfill QX placements QX to Middle our the from was million, quarter were from important of more International areas quarter the balloon approximately of of the In roughly account gen QX for revenue patient was XXX% XXXX U.S. greatest full about Overall $X up the XXXX. the in Perhaps from six patients highest for $X.X the existing was to-date $XXX,XXX accounts as account unaudited million, XXXX. of revenue was in from the stocking any million the our Preliminary in approximately new of number treating According revenue to balloon new in U.S. quarter highest to-date. of unaudited continue accounts year For approximately commercial from XXXX. revenues any initial fourth reorder distributor over preliminary improvement a long-term. $XXX,XXX time, in the new up XXXX or even $XX.X
international We opportunity and believe highest continue do East. in beyond, not U.S. the greatest plans and current make our our distributor the the to for we have meaningfully expanding values Middle our for us continue XXXX U.S. to beyond creating our executing will existing in priority
very patient performance seeking over period. our in would that are in to the was substantially weight QX counter interest loss and encouraged treatment holiday We volume and belief slightly slow with XXXX revenue it the
patient was in ahead some quarter the of demand patient purchased accounts may highest New XXXX, the any anticipation have Year. believe in with While demand higher associated of we
or would to this year’s new expect, what you we running a we At not weight able project As resolution reorder QX these in promotion. volume sales are are new time XXXX. dynamics will on loss account have impact
time to this require back requested clock. additional the addition as was is unusual, review not have we and a do once In major to as a we the At as would Because best we letter FDA loss for filling, loss such this believe the complete expect PMAs follow-up on a Navigation not and rejection, data term asked most efficient means working provide we or the are durability. For response data. the weight we things not clinical determine letter data weight us deficiency FDA. from received be provide longer the such clinical would to the
believe The current balloon system, into Finally system in is and we’d also and combine in this ease which for of market of terms both infancy a to opportunity in its to single further use. plan safety use Touch improvements we provide the Obalon development. will Navigation the
year progress commercial in U.S. We are by sales. full our encouraged of and of success our first level
provides providers. important strong our experience reinforce Obalon's very there and for because belief transfers outcomes a Our the significant problem, unique to balloon, swallowable is that solves in continues to economic gas-filled it large
required We like the valuable to operator, Obalon. call very line the would please will will believe a its potential now I continue hand investments the operator the over you to the market to be create open for we continue I franchise. sustainable and now future business to develop make to and optimistic for are the to questions. about